Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent

OBJECTIVES: To compare the efficacy and safety of the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent (DTS) and the sirolimus‐eluting Orsiro stent (O‐SES) in patients with and without acute coronary syndrome (ACS) included in the SORT OUT X study. BACKGROUND: The incidence of target...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobsen, Lars, Christiansen, Evald H., Freeman, Phillip, Kahlert, Johnny, Veien, Karsten, Maeng, Michael, Raungaard, Bent, Ellert, Julia, Kristensen, Steen D., Christensen, Martin K., Terkelsen, Christian J., Thim, Troels, Eftekhari, Ashkan, Jensen, Rebekka V., Støttrup, Nicolaj B., Junker, Anders, Hansen, Henrik S., Jensen, Lisette O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100152/
https://www.ncbi.nlm.nih.gov/pubmed/36378691
http://dx.doi.org/10.1002/ccd.30480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100152/
https://www.ncbi.nlm.nih.gov/pubmed/36378691
http://dx.doi.org/10.1002/ccd.30480

Ejemplares similares